Tatva Chintan Pharma Chem Limited IPO (TATVA)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Tatva Chintan Pharma Chem Limited IPO?
The Tatva Chintan Pharma Chem Limited IPO price band is Rs.1073 to Rs.1083 per share.
When does the Tatva Chintan Pharma Chem Limited IPO open and close?
Bidding opens 16 July 2021 and closes 20 July 2021.
Is the Tatva Chintan Pharma Chem Limited IPO a mainboard or SME issue?
Tatva Chintan Pharma Chem Limited is a mainboard IPO, listing on NSE's main board.
When did the Tatva Chintan Pharma Chem Limited IPO list?
Tatva Chintan Pharma Chem Limited listed on 29 July 2021.
Does this page show the grey market premium (GMP) for Tatva Chintan Pharma Chem Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Tatva Chintan Pharma Chem Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.